Europe Prostacyclin Analog Market Research Report Forecast 2017 to 2022

December 2017 | 136 pages | ID: E82CC01D8A7EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Prostacyclin Analog Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Prostacyclin Analog industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Prostacyclin Analog market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Prostacyclin Analog Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Actelion Pharmaceuticals
United Therapeutics Corporation
Gilead
Bayer AG
SteadyMed
GlaxoSmithKline
Pfizer
Reata Pharmaceuticals
Arena Pharmaceuticals

Europe Prostacyclin Analog Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Prostacyclin Analog Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 PROSTACYCLIN ANALOG MARKET OVERVIEW

1.1 Product Overview and Scope of Prostacyclin Analog
1.2 Classification of Prostacyclin Analog
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Prostacyclin Analog
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Prostacyclin Analog Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Prostacyclin Analog (2012-2022)
  1.5.1 Europe Prostacyclin Analog Sales and Growth Rate (2012-2022)
  1.5.2 Europe Prostacyclin Analog Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON PROSTACYCLIN ANALOG INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 PROSTACYCLIN ANALOG MANUFACTURING COST ANALYSIS

3.1 Prostacyclin Analog Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Prostacyclin Analog

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Prostacyclin Analog Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Prostacyclin Analog Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE PROSTACYCLIN ANALOG MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Prostacyclin Analog Market Competition by Manufacturers
  5.1.1 Europe Prostacyclin Analog Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Prostacyclin Analog Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Prostacyclin Analog (Volume and Value) by Type
  5.2.1 Europe Prostacyclin Analog Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Prostacyclin Analog Revenue and Market Share by Type (2012-2017)
5.3 Europe Prostacyclin Analog (Volume and Value) by Countries
  5.3.1 Europe Prostacyclin Analog Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Prostacyclin Analog Revenue and Market Share by Countries (2012-2017)
5.4 Europe Prostacyclin Analog (Volume) by Application

6 GERMANY PROSTACYCLIN ANALOG (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Prostacyclin Analog Sales and Value (2012-2017)
  6.1.1 Germany Prostacyclin Analog Sales and Growth Rate (2012-2017)
  6.1.2 Germany Prostacyclin Analog Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Prostacyclin Analog Sales Price Trend (2012-2017)
6.2 Germany Prostacyclin Analog Sales and Market Share by Manufacturers
6.3 Germany Prostacyclin Analog Sales and Market Share by Type
6.4 Germany Prostacyclin Analog Sales and Market Share by Application

7 FRANCE PROSTACYCLIN ANALOG (VOLUME, VALUE AND SALES PRICE)

7.1 France Prostacyclin Analog Sales and Value (2012-2017)
  7.1.1 France Prostacyclin Analog Sales and Growth Rate (2012-2017)
  7.1.2 France Prostacyclin Analog Revenue and Growth Rate (2012-2017)
  7.1.3 France Prostacyclin Analog Sales Price Trend (2012-2017)
7.2 France Prostacyclin Analog Sales and Market Share by Manufacturers
7.3 France Prostacyclin Analog Sales and Market Share by Type
7.4 France Prostacyclin Analog Sales and Market Share by Application

8 UK PROSTACYCLIN ANALOG (VOLUME, VALUE AND SALES PRICE)

8.1 UK Prostacyclin Analog Sales and Value (2012-2017)
  8.1.1 UK Prostacyclin Analog Sales and Growth Rate (2012-2017)
  8.1.2 UK Prostacyclin Analog Revenue and Growth Rate (2012-2017)
  8.1.3 UK Prostacyclin Analog Sales Price Trend (2012-2017)
8.2 UK Prostacyclin Analog Sales and Market Share by Manufacturers
8.3 UK Prostacyclin Analog Sales and Market Share by Type
8.4 UK Prostacyclin Analog Sales and Market Share by Application

9 RUSSIA PROSTACYCLIN ANALOG (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Prostacyclin Analog Sales and Value (2012-2017)
  9.1.1 Russia Prostacyclin Analog Sales and Growth Rate (2012-2017)
  9.1.2 Russia Prostacyclin Analog Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Prostacyclin Analog Sales Price Trend (2012-2017)
9.2 Russia Prostacyclin Analog Sales and Market Share by Manufacturers
9.3 Russia Prostacyclin Analog Sales and Market Share by Type
9.4 Russia Prostacyclin Analog Sales and Market Share by Application

10 ITALY PROSTACYCLIN ANALOG (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Prostacyclin Analog Sales and Value (2012-2017)
  10.1.1 Italy Prostacyclin Analog Sales and Growth Rate (2012-2017)
  10.1.2 Italy Prostacyclin Analog Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Prostacyclin Analog Sales Price Trend (2012-2017)
10.2 Italy Prostacyclin Analog Sales and Market Share by Manufacturers
10.3 Italy Prostacyclin Analog Sales and Market Share by Type
10.4 Italy Prostacyclin Analog Sales and Market Share by Application

11 SPAIN PROSTACYCLIN ANALOG (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Prostacyclin Analog Sales and Value (2012-2017)
  11.1.1 Spain Prostacyclin Analog Sales and Growth Rate (2012-2017)
  11.1.2 Spain Prostacyclin Analog Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Prostacyclin Analog Sales Price Trend (2012-2017)
11.2 Spain Prostacyclin Analog Sales and Market Share by Manufacturers
11.3 Spain Prostacyclin Analog Sales and Market Share by Type
11.4 Spain Prostacyclin Analog Sales and Market Share by Application

12 BENELUX PROSTACYCLIN ANALOG (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Prostacyclin Analog Sales and Value (2012-2017)
  12.1.1 Benelux Prostacyclin Analog Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Prostacyclin Analog Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Prostacyclin Analog Sales Price Trend (2012-2017)
12.2 Benelux Prostacyclin Analog Sales and Market Share by Manufacturers
12.3 Benelux Prostacyclin Analog Sales and Market Share by Type
12.4 Benelux Prostacyclin Analog Sales and Market Share by Application

13 EUROPE PROSTACYCLIN ANALOG MANUFACTURERS ANALYSIS

13.1 Actelion Pharmaceuticals
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 United Therapeutics Corporation
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Gilead
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Bayer AG
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 SteadyMed
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 GlaxoSmithKline
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Pfizer
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Reata Pharmaceuticals
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Arena Pharmaceuticals
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE PROSTACYCLIN ANALOG MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Prostacyclin Analog Market Forecast by Type (2017-2022)
15.9 Europe Prostacyclin Analog Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostacyclin Analog
Table Classification of Prostacyclin Analog
Figure Europe Sales Market Share of Prostacyclin Analog by Type in 2016
Table Application of Prostacyclin Analog
Figure Europe Sales Market Share of Prostacyclin Analog by Application in 2016
Figure Germany Prostacyclin Analog Revenue and Growth Rate (2012-2022)
Figure France Prostacyclin Analog Revenue and Growth Rate (2012-2022)
Figure UK Prostacyclin Analog Revenue and Growth Rate (2012-2022)
Figure Russia Prostacyclin Analog Revenue and Growth Rate (2012-2022)
Figure Italy Prostacyclin Analog Revenue and Growth Rate (2012-2022)
Figure Spain Prostacyclin Analog Revenue and Growth Rate (2012-2022)
Figure Benelux Prostacyclin Analog Revenue and Growth Rate (2012-2022)
Figure Europe Prostacyclin Analog Sales and Growth Rate (2012-2022)
Figure Europe Prostacyclin Analog Revenue and Growth Rate (2012-2022)
Table Europe Prostacyclin Analog Sales of Key Manufacturers (2015 and 2016)
Table Europe Prostacyclin Analog Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostacyclin Analog Sales Share by Manufacturers
Figure 2016 Prostacyclin Analog Sales Share by Manufacturers
Table Europe Prostacyclin Analog Revenue by Manufacturers (2015 and 2016)
Table Europe Prostacyclin Analog Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Prostacyclin Analog Revenue Share by Manufacturers
Table 2016 Europe Prostacyclin Analog Revenue Share by Manufacturers
Table Europe Prostacyclin Analog Sales and Market Share by Type (2012-2017)
Table Europe Prostacyclin Analog Sales Share by Type (2012-2017)
Figure Sales Market Share of Prostacyclin Analog by Type (2012-2017)
Figure Europe Prostacyclin Analog Sales Growth Rate by Type (2012-2017)
Table Europe Prostacyclin Analog Revenue and Market Share by Type (2012-2017)
Table Europe Prostacyclin Analog Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostacyclin Analog by Type (2012-2017)
Figure Europe Prostacyclin Analog Revenue Growth Rate by Type (2012-2017)
Table Europe Prostacyclin Analog Sales and Market Share by Countries (2012-2017)
Table Europe Prostacyclin Analog Sales Share by Countries (2012-2017)
Figure Sales Market Share of Prostacyclin Analog by Countries (2012-2017)
Table Europe Prostacyclin Analog Revenue and Market Share by Countries (2012-2017)
Table Europe Prostacyclin Analog Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Prostacyclin Analog by Countries (2012-2017)
Table Europe Prostacyclin Analog Sales and Market Share by Application (2012-2017)
Table Europe Prostacyclin Analog Sales Share by Application (2012-2017)
Figure Sales Market Share of Prostacyclin Analog by Application (2012-2017)
Figure Germany Prostacyclin Analog Sales and Growth Rate (2012-2017)
Figure Germany Prostacyclin Analog Revenue and Growth Rate (2012-2017)
Figure Germany Prostacyclin Analog Sales Price Trend (2012-2017)
Table Germany Prostacyclin Analog Sales by Manufacturers (2015 and 2016)
Table Germany Prostacyclin Analog Market Share by Manufacturers (2015 and 2016)
Table Germany Prostacyclin Analog Sales by Type (2015 and 2016)
Table Germany Prostacyclin Analog Market Share by Type (2015 and 2016)
Table Germany Prostacyclin Analog Sales by Application (2015 and 2016)
Table Germany Prostacyclin Analog Market Share by Application (2015 and 2016)
Figure France Prostacyclin Analog Sales and Growth Rate (2012-2017)
Figure France Prostacyclin Analog Revenue and Growth Rate (2012-2017)
Figure France Prostacyclin Analog Sales Price Trend (2012-2017)
Table France Prostacyclin Analog Sales by Manufacturers (2015 and 2016)
Table France Prostacyclin Analog Market Share by Manufacturers (2015 and 2016)
Table France Prostacyclin Analog Sales by Type (2015 and 2016)
Table France Prostacyclin Analog Market Share by Type (2015 and 2016)
Table France Prostacyclin Analog Sales by Application (2015 and 2016)
Table France Prostacyclin Analog Market Share by Application (2015 and 2016)
Figure UK Prostacyclin Analog Sales and Growth Rate (2012-2017)
Figure UK Prostacyclin Analog Revenue and Growth Rate (2012-2017)
Figure UK Prostacyclin Analog Sales Price Trend (2012-2017)
Table UK Prostacyclin Analog Sales by Manufacturers (2015 and 2016)
Table UK Prostacyclin Analog Market Share by Manufacturers (2015 and 2016)
Table UK Prostacyclin Analog Sales by Type (2015 and 2016)
Table UK Prostacyclin Analog Market Share by Type (2015 and 2016)
Table UK Prostacyclin Analog Sales by Application (2015 and 2016)
Table UK Prostacyclin Analog Market Share by Application (2015 and 2016)
Figure Russia Prostacyclin Analog Sales and Growth Rate (2012-2017)
Figure Russia Prostacyclin Analog Revenue and Growth Rate (2012-2017)
Figure Russia Prostacyclin Analog Sales Price Trend (2012-2017)
Table Russia Prostacyclin Analog Sales by Manufacturers (2015 and 2016)
Table Russia Prostacyclin Analog Market Share by Manufacturers (2015 and 2016)
Table Russia Prostacyclin Analog Sales by Type (2015 and 2016)
Table Russia Prostacyclin Analog Market Share by Type (2015 and 2016)
Table Russia Prostacyclin Analog Sales by Application (2015 and 2016)
Table Russia Prostacyclin Analog Market Share by Application (2015 and 2016)
Figure Italy Prostacyclin Analog Sales and Growth Rate (2012-2017)
Figure Italy Prostacyclin Analog Revenue and Growth Rate (2012-2017)
Figure Italy Prostacyclin Analog Sales Price Trend (2012-2017)
Table Italy Prostacyclin Analog Sales by Manufacturers (2015 and 2016)
Table Italy Prostacyclin Analog Market Share by Manufacturers (2015 and 2016)
Table Italy Prostacyclin Analog Sales by Type (2015 and 2016)
Table Italy Prostacyclin Analog Market Share by Type (2015 and 2016)
Table Italy Prostacyclin Analog Sales by Application (2015 and 2016)
Table Italy Prostacyclin Analog Market Share by Application (2015 and 2016)
Figure Spain Prostacyclin Analog Sales and Growth Rate (2012-2017)
Figure Spain Prostacyclin Analog Revenue and Growth Rate (2012-2017)
Figure Spain Prostacyclin Analog Sales Price Trend (2012-2017)
Table Spain Prostacyclin Analog Sales by Manufacturers (2015 and 2016)
Table Spain Prostacyclin Analog Market Share by Manufacturers (2015 and 2016)
Table Spain Prostacyclin Analog Sales by Type (2015 and 2016)
Table Spain Prostacyclin Analog Market Share by Type (2015 and 2016)
Table Spain Prostacyclin Analog Sales by Application (2015 and 2016)
Table Spain Prostacyclin Analog Market Share by Application (2015 and 2016)
Figure Benelux Prostacyclin Analog Sales and Growth Rate (2012-2017)
Figure Benelux Prostacyclin Analog Revenue and Growth Rate (2012-2017)
Figure Benelux Prostacyclin Analog Sales Price Trend (2012-2017)
Table Benelux Prostacyclin Analog Sales by Manufacturers (2015 and 2016)
Table Benelux Prostacyclin Analog Market Share by Manufacturers (2015 and 2016)
Table Benelux Prostacyclin Analog Sales by Type (2015 and 2016)
Table Benelux Prostacyclin Analog Market Share by Type (2015 and 2016)
Table Benelux Prostacyclin Analog Sales by Application (2015 and 2016)
Table Benelux Prostacyclin Analog Market Share by Application (2015 and 2016)
Table Actelion Pharmaceuticals Basic Information List
Table Actelion Pharmaceuticals Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Prostacyclin Analog Sales Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Prostacyclin Analog Sales Market Share (2012-2017)
Table Gilead Basic Information List
Table Gilead Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gilead Prostacyclin Analog Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Prostacyclin Analog Sales Market Share (2012-2017)
Table SteadyMed Basic Information List
Table SteadyMed Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SteadyMed Prostacyclin Analog Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Prostacyclin Analog Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Prostacyclin Analog Sales Market Share (2012-2017)
Table Reata Pharmaceuticals Basic Information List
Table Reata Pharmaceuticals Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Prostacyclin Analog Sales Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Prostacyclin Analog Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostacyclin Analog
Figure Manufacturing Process Analysis of Prostacyclin Analog
Figure Prostacyclin Analog Industrial Chain Analysis
Table Raw Materials Sources of Prostacyclin Analog Major Manufacturers in 2016
Table Major Buyers of Prostacyclin Analog
Table Distributors/Traders List
Figure Germany Prostacyclin Analog Sales and Growth Rate Forecast (2017-2022)
Figure Germany Prostacyclin Analog Revenue and Growth Rate Forecast (2017-2022)
Figure France Prostacyclin Analog Sales and Growth Rate Forecast (2017-2022)
Figure France Prostacyclin Analog Revenue and Growth Rate Forecast (2017-2022)
Figure UK Prostacyclin Analog Sales and Growth Rate Forecast (2017-2022)
Figure UK Prostacyclin Analog Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Prostacyclin Analog Sales and Growth Rate Forecast (2017-2022)
Figure Russia Prostacyclin Analog Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Prostacyclin Analog Sales and Growth Rate Forecast (2017-2022)
Figure Italy Prostacyclin Analog Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Prostacyclin Analog Sales and Growth Rate Forecast (2017-2022)
Figure Spain Prostacyclin Analog Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Prostacyclin Analog Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Prostacyclin Analog Revenue and Growth Rate Forecast (2017-2022)
Table Europe Prostacyclin Analog Sales Forecast by Type (2017-2022)
Table Europe Prostacyclin Analog Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Actelion Pharmaceuticals
United Therapeutics Corporation
Gilead
Bayer AG
SteadyMed
GlaxoSmithKline
Pfizer
Reata Pharmaceuticals
Arena Pharmaceuticals
Merck